EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET ANALYSIS

Extracorporeal Membrane Oxygenation System Market, by Modality (Arteriovenous, Venoarteial, and Venovenous) by Application (Extracorporeal cardiopulmonary resuscitation, Cardiac, and Respiratory), by Age Group (Neonatal, Pediatric, and Adults), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022
Code : CMI947
Pages :170
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Extracorporeal Membrane Oxygenation System Market: Key Developments

In May 2022, LivaNova PLC, a global medical technology company, acquired ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure

In January 2021, Braile Biomedica, an advanced manufacturer of medical-surgical and hospital products, launched SOLIS System, a product against COVID-19 in partnership with the Eldorado Institute, a non-profit research, development and innovation institution, and Embrapii, a social organization. The system consists of extracorporeal membrane oxygenation (ECMO), a form of extracorporeal breathing.